Tuesday, 22 Oct 2019

You are here

The RheumNow Week in Review – 17 February 2017

Dr. Jack Cush reviews this week's news and information from the 2017 RWCS meeting in Maui.

  1. 5yr study of inpatient gout flares - predictors include GI Bleed, urinary catheter or Abx use. Dr Orrin Troum lectures from RWCS2017 by https://t.co/uup3sbK8Hd
  2. RA patients having all 3 of the following factors (seropositivity; high IgG levels; detectable serum IL-33) in a cohort study shown to have a 100% response to Rituximab https://t.co/z6x1l5TgEa
  3. Abbvies JAK inhibitor (ABT-494) has a name, Uptacitinib, is currently in phIII trials. #RWCS 2017 info from Dr. M Genovese
  4. Rare cause of RA with lymphadenopathy - Think Angioimmunoblastic T-cell lymphoma: rare; with LN, fever, rash, organomegaly polyarthritis https://t.co/HWWFzWQTQk
  5. 43% of 550 RA pts have ILD. 70% occurred within 10 yrs of RA onset, w/ reticular & ground-glass patterns, most NSIP https://t.co/Vt5BFYZhLN
  6. Study shows HBV reactivation w/ tocilizumab Rx only with Chronic HBV, not Resolved HBV - Do HBV testing with TCZ! https://t.co/NZQXQ8xWHB
  7. Kikuchis disease commonly associates with SLE - review of 138 patients with fever, necrotizing lymphadenitis, less nephritis https://t.co/NZQXQ8xWHB
  8. In animal models, abatacept and tofacitinib shown effective in treating suppressing Chikungunya arthritis. https://t.co/LOAinXNOON
  9. Brodalumab is FDA Approved for Psoriasis but with a Black box warning for suicide
  10. Baricitinib Approved in the EU for Use in Rheumatoid Arthritis  
  11. BEAM Study: Baricitinib Beats Placebo and Adalimumab in Rheumatoid Arthritis
  12. Crohn's Arthritis Linked to E. Coli Infection.
  13. Immunosuppressives Fail to Benefit Early Skin Scleroderma
  14. Top Ten Things Rheumatologists Should Know When Ordering Imaging
  15. The Negotiator 
Disclosures: 
The author has received research/grant financial support on this subject
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast – Fight or Switching (DMARDs) (10.18.19)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

RheumNow Podcast – When You’re Hot You’re Hot (10.11.19)

Dr. Jack Cush delivers select commentary on select news and journal articles from the past week on RheumNow.com.

RheumNow Podcast – Women Take Over Rheumatology (10.4.19)

Dr. Jack Cush reviews the News and Journal Reports from this week on RheumNow.com.

Increasingly Women are Choosing Subspecialty Careers

JAMA Internal Medicine has an analysis of the growing trend of more women enrolling in medical schools in the last few decades, such that more than half of US Med school matriculants in 2017 were women.  Also in 2017, 42% of residents in internal medicine were women.  The reported analysis looked at internal medicine subspecialty choices by women and men between 1991 to 2016.

 

RheumNow Podcast – Cancer Risk in Systemic Sclerosis (9.27.19)

Dr. Jack Cush reviews the news and articles from the past week on RheumNow.com.